<DOC>
	<DOCNO>NCT00314574</DOCNO>
	<brief_summary>This multicenter , randomize , double-blind , placebo-controlled study efficacy , safety , tolerability subcutaneously administer Xolair add-on therapy treatment subject age 12-75 year old diagnose moderate severe asthma inadequately control high-dose inhaled corticosteroid ( ICS ) + long-acting beta-agonists ( LABA ) without additional controller therapy .</brief_summary>
	<brief_title>A Study Omalizumab ( Xolair ) Subjects With Moderate Severe Persistent Asthma ( EXTRA )</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Omalizumab</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<criteria>Signed Informed Consent Form inform assent , applicable Be age 12 75 year Have history moderate severe asthma least one year prior screen Have treatment stable regimen salmeterol 50 µg twice day ( BID ) formoterol 12 µg BID least 8 week prior screen Have treatment stable regimen highdose inhaled corticosteroid ( ICS ) least 8 week prior screen Have inadequately control asthma Have least one asthma exacerbation require systemic corticosteroid rescue 12 month prior screen visit receive treatment highdose ICS Have le 10 packyears smoke history Have positive skin test positive , vitro response one relevant perennial aeroallergen document within 12 month prior screen If subject positive skin test vitro reactivity 12 month prior screen , subject must demonstrate positive response least one relevant perennial aeroallergen skin vitro test prior randomization Female subject childbearing potential must use effective method contraception screen duration participation study For collection additional blood sample future research ( optional ) , provide sign consent inform assent , applicable . Have asthma exacerbation require intubation within 12 month prior screen Have active lung disease asthma Have asthma exacerbation require treatment addition systemic ( oral intravenous ) corticosteroid increase systemic corticosteroid within 30 day prior screen Require chronic immunosuppressive therapy include cyclosporine , methotrexate , etc . Have significant medical illness asthma Have take methotrexate , gold salt , cyclosporine , macrolide antibiotic , within 3 month prior screen Have take investigational drug within 30 day prior screen Have treat Xolair within 12 month prior screen Have history drug alcohol abuse , judgment investigator , may put subject risk unable participate fully study duration study Have elevate serum IgE level reason allergy Are pregnant lactating</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Persistent Asthma</keyword>
	<keyword>EXTRA</keyword>
	<keyword>Xolair</keyword>
	<keyword>Difficult Breathing</keyword>
</DOC>